-
摘要: 甲状腺内胸腺癌(intrathyroid thymic carcinoma，ITTC)是一种罕见的甲状腺肿瘤，缺乏典型的临床表现及影像学特征，术前诊断较为困难，根治性手术治疗是其首选的治疗方式，术后是否辅以放化疗，尚无明确结论。本文报道1例ITTC患者，分析该病例临床资料并结合相关文献，探讨ITTC的临床表现、诊疗及预后。
-
关键词:
- 甲状腺内胸腺癌 /
- 甲状腺显示胸腺样分化癌 /
- 甲状腺
Abstract: Intrathyroid thymic carcinoma(ITTC) is a rare thyroid tumor that lacks typical clinical manifestations and imaging features, making preoperative diagnosis challenging.The primary treatment for ITTC is radical surgery; however, the effectiveness of adjuvant radiotherapy and chemotherapy post-surgery is not well-established. This paper presents a case of ITTC, analyzing the clinical data and correlating it with the literature to explore the clinical manifestations, diagnostic approach, treatment, and prognosis of ITTC. -
-
-
[1] Wong EHC, Tetter N, Tzankov A, et al. CASTLE tumor of the parotid: first documented case, literature review, and genetic analysis of the cancer[J]. Head Neck, 2018, 40(1): E1-e4. doi: 10.1002/hed.24946
[2] Okubo Y, Sakai M, Yamazaki H, et al. Histopathological study of carcinoma showing Thymus-like differentiation(CASTLE)[J]. Malays J Pathol, 2020, 42(2): 259-265.
[3] Hanamura T, Ito K, Uehara T, et al. Chemosensitivity in carcinoma showing Thymus-like differentiation: a case report and review of the literature[J]. Thyroid, 2015, 25(8): 969-972. doi: 10.1089/thy.2015.0155
[4] Hsu HT, Lin YZ, Yeh CW, et al. Nontender mass on the right side of the neck. Carcinoma showing Thymus-like differentiation(CASTLE)[J]. JAMA Otolaryngol Head Neck Surg, 2014, 140(3): 269-270. doi: 10.1001/jamaoto.2013.6293
[5] Ge W, Yao YZ, Chen G, et al. Clinical analysis of 82 cases of carcinoma showing Thymus-like differentiation of the thyroid[J]. Oncol Lett, 2016, 11(2): 1321-1326. doi: 10.3892/ol.2015.4055
[6] Dang NV, Son LX, Hong NTT, et al. Recurrence of carcinoma showing Thymus-like differentiation(CASTLE)involving the thyroid gland[J]. Thyroid Res, 2021, 14(1): 20. doi: 10.1186/s13044-021-00111-3
[7] Dong WW, Zhang P, Li J, et al. Outcome of thyroid carcinoma showing Thymus-like differentiation in patients undergoing radical resection[J]. World J Surg, 2018, 42(6): 1754-1761. doi: 10.1007/s00268-017-4339-2
[8] Wu B, Sun TQ, Gu YJ, et al. CT and MR imaging of thyroid carcinoma showing Thymus-like differentiation(CASTLE): a report of ten cases[J]. Br J Radiol, 2016, 89(1060): 20150726. doi: 10.1259/bjr.20150726
[9] Gurizzan C, Zamparini M, Volante M, et al. Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis[J]. Endocr Relat Cancer, 2021, 28(8): 593-604. doi: 10.1530/ERC-21-0123
[10] Li JY, Xiang R, Li YZ, et al. Intrathyroid thymic carcinoma: clinicopathological features and whole exome sequencing analysis[J]. Virchows Arch, 2023, 482(5): 813-822. doi: 10.1007/s00428-023-03536-3
[11] Weissferdt A, Moran CA. Ectopic primary intrathyroidal thymoma: a clinicopathological and immunohistochemical analysis of 3 cases[J]. Hum Pathol, 2016, 49: 71-76. doi: 10.1016/j.humpath.2015.10.011
[12] 陈博婕, 李欣洋, 王卓颖, 等. 误诊为甲状腺结节的颈部异位胸腺瘤1例[J]. 临床耳鼻咽喉头颈外科杂志, 2020, 34(10): 947-949. https://lceh.whuhzzs.com/article/doi/10.13201/j.issn.2096-7993.2020.10.019
[13] Zhao YJ, Liu JF. Case report: thymoid differentiated carcinoma of thyroid: two cases[J]. Front Surg, 2023, 10: 1112315. doi: 10.3389/fsurg.2023.1112315
[14] 张思瑶, 孙庆佳, 朱冬冬. 甲状腺滤泡癌下颌骨上支孤立转移1例[J]. 临床耳鼻咽喉头颈外科杂志, 2023, 37(7): 574-577. https://lceh.whuhzzs.com/article/doi/10.13201/j.issn.2096-7993.2023.07.012
[15] Wang YF, Liu B, Fan XS, et al. Thyroid carcinoma showing Thymus-like elements: a clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis[J]. Am J Clin Pathol, 2015, 143(2): 223-233. doi: 10.1309/AJCPB7PS6QHWEFRK
[16] Suzuki A, Hirokawa M, Takada N, et al. Utility of monoclonal PAX8 antibody for distinguishing intrathyroid thymic carcinoma from follicular cell-derived thyroid carcinoma[J]. Endocr J, 2018, 65(12): 1171-1175. doi: 10.1507/endocrj.EJ18-0282
[17] Tsutsui H, Hoshi M, Kubota M, et al. Management of thyroid carcinoma showing Thymus-like differentiation(CASTLE)invading the Trachea[J]. Surg Today, 2013, 43(11): 1261-1268. doi: 10.1007/s00595-013-0560-2
[18] Liu Z, Teng XY, Sun DX, et al. Clinical analysis of thyroid carcinoma showing Thymus-like differentiation: report of 8 cases[J]. Int Surg, 2013, 98(2): 95-100. doi: 10.9738/INTSURG-D-12-00034.1
[19] Gao R, Jia X, Ji T, et al. Management and prognostic factors for thyroid carcinoma showing Thymus-like elements(CASTLE): a case series study[J]. Front Oncol, 2018, 8: 477. doi: 10.3389/fonc.2018.00477
[20] Yuan Y, Ke CS, Zhang GP, et al. Case report and literature review: thyroid carcinoma showing intrathyroid thymic carcinoma[J]. Front Oncol, 2022, 12: 923683. doi: 10.3389/fonc.2022.923683
[21] Gurizzan C, Zamparini M, Volante M, et al. Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis[J]. Endocr Relat Cancer, 2021, 28(8): 593-604. doi: 10.1530/ERC-21-0123
[22] Lominska C, Estes CF, Neupane PC, et al. CASTLE thyroid tumor: a case report and literature review[J]. Front Oncol, 2017, 7: 207. doi: 10.3389/fonc.2017.00207
[23] Kiyota N, Robinson B, Shah M, et al. Defining radioiodine-refractory differentiated thyroid cancer: efficacy and safety of lenvatinib by radioiodine-refractory criteria in the SELECT trial[J]. Thyroid, 2017, 27(9): 1135-1141. doi: 10.1089/thy.2016.0549
[24] Covell LL, Ganti AK. Treatment of advanced thyroid cancer: role of molecularly targeted therapies[J]. Target Oncol, 2015, 10(3): 311-324. doi: 10.1007/s11523-014-0331-z
-
下载:
图(1)
计量
- 文章访问数: 507
- PDF下载数: 56
- 施引文献: 0